T2DM with progressive liver fibrosis | p value | T2DM without progressive liver fibrosis | p value | |||
---|---|---|---|---|---|---|
NFS > 0.676(n = 93) | NFS < 0.676(493) | |||||
without NAFLD (n = 45) | with NAFLD (n = 48) | without NAFLD (n = 195) | with NAFLD (n = 298) | |||
Sex (male/female) | 13/32 | 21/27 | 0.137 | 88/107 | 141/157 | 0.634 |
Age (years) | 72.27 ± 8.14 | 69.92 ± 8.92 | 0.189 | 60(53–66) | 56(51–64) | 0.025 |
FT3(pmol/L) | 3.81 ± 0.56 | 3.95 ± 0.50 | 0.199 | 3.98 ± 0.50 | 4.06 ± 0.47 | 0.081 |
FT4(pmol/L) | 13.04 ± 1.57 | 12.55 ± 1.40 | 0.113 | 13.47 ± 1.51 | 13.12 ± 2.49 | 0.013 |
TT3(nmol/L) | 1.29 ± 0.20 | 1.36 ± 0.20 | 0.067 | 1.40 ± 0.22 | 1.42 ± 0.23 | 0.215 |
TT4(nmol/L) | 83.67 ± 11.55 | 83.08 ± 13.58 | 0.822 | 85.05(75.20–97.68) | 84.61(73.27–95.96) | 0.342 |
TSH (uIU/L) | 2.3177 ± 0.9937 | 2.5104 ± 1.1098 | 0.381 | 2.0187(1.4134–2.8459) | 2.0308(1.3439–2.7457) | 0.537 |
FT3/FT4 | 0.295 ± 0.052 | 0.317 ± 0.045 | 0.032 | 0.298 ± 0.042 | 0.312 ± 0.045 | 0.000 |